Paper37965331
Histone lactylation regulates cancer progression by reshaping the tumor microenvironment.
Qu J and 2 others. Front Immunol, 2023. Cited by 120 papers, by iCite.
Cite this record
ConductScience Library. Histone lactylation regulates cancer progression by reshaping the tumor microenvironment. Papers, record 37965331. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37965331
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Histone lactylation regulates cancer progression by reshaping the tumor microenvironment.
- PubMed
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Histones | Major topic |
| Neoplasms | Major topic |
| Humans | |
| Tumor Microenvironment | |
| Lactic Acid | |
| Cell Differentiation |
Source PubMed
References117
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 34150616 | Lactate Modulates Cellular Metabolism Through Histone Lactylation-Mediated Gene Expression in Non-Small Cell Lung Cancer. | Front Oncol | 2021 | https://conductscience.org/library/papers/34150616 | PubMed |
| 2 | 35732125 | Tumor metabolite lactate promotes tumorigenesis by modulating MOESIN lactylation and enhancing TGF-β signaling in regulatory T cells. | Cell Rep | 2022 | https://conductscience.org/library/papers/35732125 | PubMed |
| 3 | 35959377 | Enterobacterial LPS-inducible LINC00152 is regulated by histone lactylation and promotes cancer cells invasion and migration. | Front Cell Infect Microbiol | 2022 | https://conductscience.org/library/papers/35959377 | PubMed |
| 4 | 35605812 | Demethylzeylasteral targets lactate by inhibiting histone lactylation to suppress the tumorigenicity of liver cancer stem cells. | Pharmacol Res | 2022 | https://conductscience.org/library/papers/35605812 | PubMed |
| 5 | 33726814 | Histone lactylation drives oncogenesis by facilitating m6A reader protein YTHDF2 expression in ocular melanoma. | Genome Biol | 2021 | https://conductscience.org/library/papers/33726814 | PubMed |
| 6 | 37170646 | Global profiling of lysine lactylation in human lungs. | Proteomics | 2023 | https://conductscience.org/library/papers/37170646 | PubMed |
| 7 | 31901298 | Histone Lactylation: A New Role for Glucose Metabolism. | Trends Biochem Sci | 2020 | https://conductscience.org/library/papers/31901298 | PubMed |
| 8 | 36724072 | Numb/Parkin-directed mitochondrial fitness governs cancer cell fate via metabolic regulation of histone lactylation. | Cell Rep | 2023 | https://conductscience.org/library/papers/36724072 | PubMed |
| 9 | 37060186 | Lactate-induced protein lactylation: A bridge between epigenetics and metabolic reprogramming in cancer. | Cell Prolif | 2023 | https://conductscience.org/library/papers/37060186 | PubMed |
| 10 | 28604752 | Tumor cell-derived lactate induces TAZ-dependent upregulation of PD-L1 through GPR81 in human lung cancer cells. | Oncogene | 2017 | https://conductscience.org/library/papers/28604752 | PubMed |
| 11 | 36050306 | Lactate metabolism in human health and disease. | Signal Transduct Target Ther | 2022 | https://conductscience.org/library/papers/36050306 | PubMed |
| 12 | 33045661 | Current development of CBP/p300 inhibitors in the last decade. | Eur J Med Chem | 2021 | https://conductscience.org/library/papers/33045661 | PubMed |
| 13 | 33589820 | Metabolic support of tumour-infiltrating regulatory T cells by lactic acid. | Nature | 2021 | https://conductscience.org/library/papers/33589820 | PubMed |
| 14 | 30029203 | Cancer stem cell in breast cancer therapeutic resistance. | Cancer Treat Rev | 2018 | https://conductscience.org/library/papers/30029203 | PubMed |
| 15 | 21376230 | Hallmarks of cancer: the next generation. | Cell | 2011 | https://conductscience.org/library/papers/21376230 | PubMed |
| 16 | 36567801 | Altered phenotypic and metabolic characteristics of FOXP3+CD3+CD56+ natural killer T (NKT)-like cells in human malignant pleural effusion. | Oncoimmunology | 2023 | https://conductscience.org/library/papers/36567801 | PubMed |
| 17 | 36209908 | HIF1α lactylation enhances KIAA1199 transcription to promote angiogenesis and vasculogenic mimicry in prostate cancer. | Int J Biol Macromol | 2022 | https://conductscience.org/library/papers/36209908 | PubMed |
| 18 | 32102348 | Lactate in Sarcoma Microenvironment: Much More than just a Waste Product. | Cells | 2020 | https://conductscience.org/library/papers/32102348 | PubMed |
| 19 | 35794625 | Crosstalk among m6A RNA methylation, hypoxia and metabolic reprogramming in TME: from immunosuppressive microenvironment to clinical application. | J Hematol Oncol | 2022 | https://conductscience.org/library/papers/35794625 | PubMed |
| 20 | 34713630 | Genetic Code Expansion Tools to Study Lysine Acylation. | Adv Biol (Weinh) | 2021 | https://conductscience.org/library/papers/34713630 | PubMed |
Cited by104
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 120 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42983151 | H3K18 lactylation promotes osteosarcoma cell proliferation and migration through transcriptional activation of m6A reader YTHDF2. | In Vitro Cell Dev Biol Anim | 2026 | https://conductscience.org/library/papers/42983151 | PubMed |
| 42927093 | H3K18 lactylation promotes Treg/Th17 imbalance via PTPRM-STAT3 axis in hepatocellular carcinoma. | iScience | 2026 | https://conductscience.org/library/papers/42927093 | PubMed |
| 42835188 | Exercise-induced protein lactylation: From molecular mechanisms to precision health applications. | iScience | 2026 | https://conductscience.org/library/papers/42835188 | PubMed |
| 42793282 | Lactylation Remodels Tumorigenesis, Immune Microenvironment, and Therapeutic Response. | Curr Issues Mol Biol | 2026 | https://conductscience.org/library/papers/42793282 | PubMed |
| 42751446 | The multifaceted functions of lactate and its translational potentials in cancer. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42751446 | PubMed |
| 42738864 | Lactate Metabolism and Signaling in Amyotrophic Lateral Sclerosis. | Cells | 2026 | https://conductscience.org/library/papers/42738864 | PubMed |
| 42703165 | Lactate-Mediated Lysine Lactylation in Renal Fibrosis: Current Progress and Challenges. | FASEB J | 2026 | https://conductscience.org/library/papers/42703165 | PubMed |
| 42663294 | Research progress on lactate metabolism in lung cancer: Tumorigenesis, drug resistance and clinical translation (Review). | Oncol Rep | 2026 | https://conductscience.org/library/papers/42663294 | PubMed |
| 42613511 | Lactylation of GDF15 Regulates Angiogenesis in Ischemic Stroke via Activating PI3K/AKT/mTOR Pathway. | Mol Neurobiol | 2026 | https://conductscience.org/library/papers/42613511 | PubMed |
| 42534222 | Mechanistic Studies of Lactate in Heart Failure: From Metabolic Biomarker to Therapeutic Target. | Rev Cardiovasc Med | 2026 | https://conductscience.org/library/papers/42534222 | PubMed |
| 42488336 | Research progress of lactylation modification in tumors (Review). | Exp Ther Med | 2026 | https://conductscience.org/library/papers/42488336 | PubMed |
| 42471662 | Protein lactylation in cancer: principles, programmes and therapeutic opportunities. | Mol Cancer | 2026 | https://conductscience.org/library/papers/42471662 | PubMed |
| 42464655 | The neural stem cell‑NSCLC axis: Molecular drivers, microenvironment crosstalk and emerging therapies (Review). | Int J Oncol | 2026 | https://conductscience.org/library/papers/42464655 | PubMed |
| 42445563 | Mechanisms of Macrophage Glycolytic Reprogramming and Interventional Effects of Traditional Chinese Medicine on Renal Fibrosis. | Int J Gen Med | 2026 | https://conductscience.org/library/papers/42445563 | PubMed |
| 42438784 | SPP1+ Macrophages Promote Immunosuppression in Post-TACE Hepatocellular Carcinoma Involving Lactate-Induced Lactylation and Potential SPP1-CD44 Signaling. | J Hepatocell Carcinoma | 2026 | https://conductscience.org/library/papers/42438784 | PubMed |
| 42363192 | DHX9 transcriptional upregulation and lactylation at K1024 fuels a glycolysis-histone lactylation loop in osteosarcoma. | J Transl Med | 2026 | https://conductscience.org/library/papers/42363192 | PubMed |
| 42359706 | Understanding the epigenetic regulation of lactylation and aberrant lactate metabolism in cancer: From mechanisms to therapeutic strategies (Review). | Int J Oncol | 2026 | https://conductscience.org/library/papers/42359706 | PubMed |
| 42353599 | Metabolic Signaling Meets Epigenetic Regulation: How Protein Lactylation Remodels the Tumor Immune Microenvironment in Gastric Cancer. | Curr Issues Mol Biol | 2026 | https://conductscience.org/library/papers/42353599 | PubMed |
| 42337599 | Histone lactylation: a novel epigenetic bridge linking cellular metabolism to benign and malignant gynecological diseases. | Clin Epigenetics | 2026 | https://conductscience.org/library/papers/42337599 | PubMed |
| 42330082 | A lactylation- and autophagy-associated prognostic signature reveals LSEC-derived CLEC3B as a novel mediator of hepatocellular carcinoma suppression. | PLoS Comput Biol | 2026 | https://conductscience.org/library/papers/42330082 | PubMed |
Genes61
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/37965331
GET https://conductscience.org/api/papers/v1/37965331/references?page=2